My studies are focused on the liver and in different alterations in the organism during cirrhosis and chronic liver diseases, especially vascular dysfunction, endothelial-to-mesenchymal transition, lymphatic dysfunction and angiogenesis. In the recent years, I have also developed studies based on nanotechnology, hepatic regeneration in mice, microRNAs (miR-122), cancer, metastases, RNA helicases and targets of AKT (DHX15, TCF20).
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Madrid, Spain
FCRB-IDIBAPS (Barcelona)